Clinical Management and Key Considerations to Target Optimal Treatment of Inflammatory Bowel Disease.

Treatment of inflammatory bowel disease (IBD) during the early phase of the disease is important so as to avoid long-term damage from chronic inflammation. There are now multiple treatments available for moderate-to-severe IBD which when used appropriately should reduce the rate of complications.

Detalles Bibliográficos
Publicado en:Journal of Managed Care Medicine Vol. 26; no. 1; pp. 26 - 31
Autor principal: Farraye, Francis A.
Formato: CEU tables/charts Journal Article
Publicado: National Association of Managed Care Physicians, Inc. 2023
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=175422268&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 175422268
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10941525
        9084
      jtl: Journal of Managed Care Medicine
      issn: 10941525
      maglogo: N
    pubinfo:
      dt: 2023
      vid: 26
      iid: 1
      pid: 54351
      pub: National Association of Managed Care Physicians, Inc.
      place: Glen Allen, Virginia
    artinfo:
      ui:
        175422268
        175422268
        175422268
        175422268
      ppf: 26
      ppct: 5
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Clinical Management and Key Considerations to Target Optimal Treatment of Inflammatory Bowel Disease.
      aug:
        au: Farraye, Francis A.
        affil: Professor of Medicine at the Mayo Clinic College of Medicine
      sug:
        subj:
          Inflammatory Bowel Diseases Drug Therapy
          Early Diagnosis
          Disease Management
          Education, Continuing (Credit)
          Anemia
          Intestinal Perforation
          Intestinal Fistula
          Anus Diseases
          Colorectal Neoplasms
          Malnutrition
          Janus Kinase Inhibitors Therapeutic Use
          Immunosuppressive Agents Therapeutic Use
      ab: Treatment of inflammatory bowel disease (IBD) during the early phase of the disease is important so as to avoid long-term damage from chronic inflammation. There are now multiple treatments available for moderate-to-severe IBD which when used appropriately should reduce the rate of complications.
      pubtype: Academic Journal
      doctype:
        CEU
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N